AI agent performs brain injection on living mouse
A biotech startup successfully used an AI agent to select a gene therapy and control a robotic surgical setup during a procedure on a mouse.
An AI agent successfully carried out a brain injection procedure on a living mouse to test a gene therapy for epilepsy. Gabriel Ocana Santero, CEO and cofounder of Exin Therapeutics, used the agent to select a treatment from 19 options, determine the brain region and injection coordinates, and control robotic arms and an injector needle.
The experiment used a custom-built surgical rig that included a motorized device to immobilize the mouse and a camera for the agent to observe the procedure. While a veterinary surgeon performed the initial craniotomy, the agent controlled the injection volume and speed.
The team initially attempted to use Anthropic’s Claude Opus 5.5 model, but the agent refused to guide the needle because it suggested the action might endanger the animal. The researchers switched to Claude Sonnet 5, which agreed to proceed with the injection.
Technical issues occurred when a glitch disrupted the equipment's coordinate system. Although the agent recognized the position was wrong, it refused to modify the code to fix it because its instructions prohibited such changes. The team used a separate AI agent on Opus 5 to make the necessary code changes, which delayed the procedure and caused the experiment to last slightly longer than an hour.
Santero said the team is waiting for the therapy to take effect to assess its impact on seizures. The company is also experimenting with agent-controlled craniotomies, though they intend to ensure safety before moving to live surgeries.
Key facts
- Gabriel Ocana Santero's startup, Exin Therapeutics, used an AI agent to perform a brain injection on a mouse.
- The AI agent selected a gene therapy from 19 options and controlled the robotic injection parameters.
- The procedure was delayed to over an hour due to a technical glitch and the agent's refusal to modify its own code.
Three perspectives
Neutral
The experiment involved an AI agent controlling a robotic surgical rig to deliver gene therapy to a mouse.
Positive
The successful injection offers a glimpse into how AI agents could eventually become active participants in laboratory research.
Negative
A technical glitch and the agent's refusal to modify code due to instruction restrictions delayed the procedure.
Your week in news, every Wednesday
The biggest stories of the week for your edition, in your inbox every Wednesday morning, your time. Free, and you can unsubscribe at any time.